Chloroprocaine for Continuous Epidural Analgesia in Neonates and Infants
Information source: Nationwide Children's Hospital
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Neonates and Infants Who Have Received Chloroprocaine for Epidural Anesthesia.
Intervention: Chloroprocaine (Drug)
Phase: N/A
Status: Completed
Sponsored by: Joseph D. Tobias Official(s) and/or principal investigator(s): Joseph D Tobias, MD, Principal Investigator, Affiliation: Nationwide Children's Hospital
Summary
This a study to retrospectively review our experience with the use of chloroprocaine for
postoperative epidural infusions in neonates and infants. Pain scores and the need for
intravenous analgesic agents will be recorded from the records to demonstrate the efficacy
of the technique.
Clinical Details
Study design: Observational Model: Cohort, Time Perspective: Retrospective
Primary outcome: Pain score
Secondary outcome: Pain medicine consumption
Eligibility
Minimum age: N/A.
Maximum age: 2 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Neonates and infants who have received chloroprocaine for epidural anesthesia.
Exclusion Criteria:
- None
Locations and Contacts
Nationwide Children's Hospital, Columbus, Ohio 43205, United States
Additional Information
Starting date: June 2014
Last updated: August 5, 2015
|